Hoitt Jason
CIK 0001762572
Chief Patient Officer
Filings
7
Latest Mar 19, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
5 of 6 open-market trades scored (83% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 0% | -15.1% | -20.1% | -7.5% | -20.1% |
| 90 days | - | - | - | - | - | - |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Hoitt Jason has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PRVB | Provention Bio, Inc. | 4 | Apr 27, 2023 |
| STOK | Stoke Therapeutics, Inc. | 3 | Mar 19, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|